On 05 February 2016
Plethico Pharmaceuticals announced that the Board of Directors vide its resolution dated 05 February 2016 have approved the following:1. Appointment of Milindkumar Laxmishankar Dixit as an Independent Director (Additional Director) on the Board of the Company for a period of five years with effect from 05 February 2016 subject to approval of the members at the ensuing General Meeting.
2. Acceptance of Resignation given by Chirag Patel as Whole time director of the Company. Chirag Patel has resigned with effect from 05 February 2016 from the position of Whole Time Director of the Company.
3. Adoption of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) including authorizing Shashikant Patel, Chairman and Managing Director of the Company to enter into amended Listing Agreement and submission of the same to BSE and any other applicable authorities, if required.
4. The re-constitution of Committees.
5. As per section 178 of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Remuneration Committee has been renamed with Nomination and remuneration Committee w.e.f. 05 February 2016.
Powered by Capital Market - Live News